The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils
Open accessAbstract
The aggregation of alpha-synuclein has been implicated as a critical step in the development of Parkinson's disease. Parkinson's disease is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons from the substantia nigra; currently, no cure exists. Baicalein is a flavonoid with antioxidant properties; upon oxidation, it forms several products including quinones. We show here that low micromolar concentrations of baicalein, and especially its oxidized forms, inhibit the formation of alpha-synuclein fibrils. In addition, existing fibrils of alpha-synuclein are disaggregated by baicalein. The product of the inhibition reaction is predominantly a soluble oligomer of alpha-synuclein, in which the protein molecules have been covalently modified by baicalein quinone to form a Schiff base with a lysine side chain in alpha-synuclein. The binding of baicalein was abolished by conversion of the Tyr residues into Phe, demonstrating that Tyr is involved in the interaction of alpha-synuclein with baicalein. In disaggregation baicalein causes fragmentation throughout the length of the fibril. These observations suggest that baicalein and similar compounds may have potential as therapeutic leads in combating Parkinson's disease and that diets rich in flavonoids may be effective in preventing the disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic Hydrocarbons
Benesi, H. A., & Hildebrand, J. H. (1949) · Journal of the American Chemical Society · doi:10.1021/ja01176a030 · Cited by 8,004
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T
Naiki, H., Higuchi, K., Hosokawa, M., & Takeda, T. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90046-8 · Cited by 1,223
Nielsen, L., Khurana, R., Coats, A., Frokjaer, S., Brange, J., Vyas, S., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi002555c · Cited by 1,175
Self-citationOxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126
Joseph, J. A., Shukitt-Hale, B., Denisova, N. A., Bielinski, D., Martin, A., McEwen, J. J., & Bickford, P. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-08114.1999 · Cited by 980
Lashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 805
Pathoanatomy of Parkinson’s disease
Braak, H., & Braak, E. (2000) · Journal of Neurology · doi:10.1007/pl00007758 · Cited by 693
Volles, M. J., Lee, S.-J., Rochet, J.-C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682
Intake of flavonoids and risk of dementia
Commenges, D., Scotet, V., Renaud, S., Jacqmin-Gadda, H., Barberger-Gateau, P., & Dartigues, J.-F. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007614613771 · Cited by 634
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Asanuma, M., Miyazaki, I., & Ogawa, N. (2003) · Neurotoxicity Research · doi:10.1007/bf03033137 · Cited by 516
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Volles, M. J., & Lansbury, P. T. (2003) · Biochemistry · doi:10.1021/bi030086j · Cited by 433
Butterfield, D. A., & Kanski, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00249-4 · Cited by 419
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0319 · Cited by 407
Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin.
Shieh, D., Liu, L., & Lin, C. C. (2000) · PubMed · Cited by 347
Khurana, R., Ionescu-Zanetti, C., Pope, M., Li, J., Nielson, L., Ramírez-Alvarado, M., Regan, L., Fink, A. L., & Carter, S. A. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74550-0 · Cited by 309
Self-citationAnguiano, M., Nowak, R. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020314u · Cited by 293
Medicinal plants and Alzheimer’s disease: From ethnobotany to phytotherapy
Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P. J., & Perry, N. S. L. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991772808 · Cited by 285
Giasson, B. I., Ischiropoulos, H., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00804-3 · Cited by 279
Gao, Z., Huang, K., & Xu, H. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0761 · Cited by 268
The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba
Watanabe, C. M. H., Wolffram, S., Ader, P., Rimbach, G., Packer, L., Maguire, J. J., Schultz, P. G., & Gohil, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111126298 · Cited by 234
Datla, K. P., Christidou, M., Widmer, W. W., Rooprai, H. K., & Dexter, D. T. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00053 · Cited by 224
The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines
Li, B. Q., Fu, T., Gong, W.-H., Dunlop, N., Kung, H.-F., Yan, Y., Kang, J., & Wang, J. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00244-7 · Cited by 219
Schroeter, H., Williams, R. J., Matin, R., Iversen, L., & Rice-Evans, C. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00415-9 · Cited by 184
Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers
Yamin, G., Uversky, V. N., & Fink, A. L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00367-3 · Cited by 167
Self-citationAnti-HIV Activity of Medicinal Herbs: Usage and Potential Development
Wu, J. A., Attele, A. S., Zhang, L., & Yuan, C.-S. (2001) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x01000083 · Cited by 158
Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses
Trojanowski, J. Q., & LEE, V. M. ‐. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07468.x · Cited by 150
Diet, body size and micronutrient status in Parkinson's disease.
Abbott, R. A., Cox, M., Markus, H. S., & Tomkins, A. M. (1992) · PubMed · Cited by 139
Spencer, J. P. E., Jenner, A. M., Butler, J., Aruoma, O. I., Dexter, D. T., Jenner, P. G., & Halliwell, B. B. (1996) · Free Radical Research · doi:10.3109/10715769609088005 · Cited by 137
Nie, G., Cao, Y., & Zhao, B. (2002) · Redox Report · doi:10.1179/135100002125000424 · Cited by 124
Ikezoe, T., Chen, S. S., Heber, D., Taguchi, H., & Koeffler, H. P. (2001) · The Prostate · doi:10.1002/pros.10024 · Cited by 120
Multiple Antioxidants in the Prevention and Treatment of Parkinson’s Disease
Prasad, K. N., Cole, W. C., & Kumar, B. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718878 · Cited by 102
El‐Agnaf, O. M. A., Nagala, S., PATEL, B. P., & Austen, B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4743 · Cited by 73
Neuroprotection by dopamine agonists
Lange, K. W., Rausch, W., Gsell, W., Naumann, M., Oestreicher, E. M., & Riederer, P. F. (1994) · PubMed · doi:10.5283/epub.25419 · Cited by 63
Howard Henry Tooth (1856-1925)
Pearce, J. (2000) · Journal of Neurology · doi:10.1007/s004150050002 · Cited by 49
Parkinson’s Disease. Methods and Protocols
Jellinger, K. A. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.0257h.x · Cited by 13
Cited by
Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications
Almanza, A., Carlesso, A., Chintha, C., Creedican, S., Doultsinos, D., Leuzzi, B., Luís, A., McCarthy, N., Montibeller, L., More, S., et al. (2019) · The FEBS Journal · doi:10.1111/febs.14608 · Cited by 1,034
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910723107 · Cited by 1,011
Porat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
α-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J. W., & Uversky, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 657
Metadata
- Authors
- Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F., & Fink, A. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 26
- Pages
- 26846-26857
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2160643911
- Cited by
- 473
- References
- 40
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.